136 related articles for article (PubMed ID: 9142190)
1. Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer.
Içli F; Karaoguz H; Akbulut H; Dinçol D; Demirkazik A; Cay F
J Surg Oncol; 1997 Apr; 64(4):318-23. PubMed ID: 9142190
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
Clark JL; Küçük O; Neuberg DS; Benson AB; Taylor SG; Pandya KJ; Mansour EG; Douglass HO; Haller DG
Am J Clin Oncol; 1995 Aug; 18(4):318-24. PubMed ID: 7625373
[TBL] [Abstract][Full Text] [Related]
3. [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
Tokunaga A; Onda M; Mizutani T; Miyamoto M; Nomura T; Hayashi H; Kiyama T; Umehara M; Nishi K; Andoh T
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3713-8. PubMed ID: 2596854
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
5. Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules.
Haim N; Tsalik M; Robinson E
Oncology; 1994; 51(1):102-7. PubMed ID: 8265093
[TBL] [Abstract][Full Text] [Related]
6. Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group.
Bajetta E; Di Bartolomeo M; de Braud F; Bozzetti F; Bochicchio AM; Comella P; Fagnani D; Farina G; Ferroni C; Franchi R
Eur J Cancer; 1994; 30A(5):596-600. PubMed ID: 8080673
[TBL] [Abstract][Full Text] [Related]
7. Etoposide, doxorubicin and cisplatin (EAP regimen) in advanced gastric cancer.
Scarpellini M; Tononi A; Pasquini E; Oliverio G; Fattori PP; Gianni L; Desiderio F; Nicolini M; Ravaioli A
J Chemother; 1994 Jun; 6(3):211-5. PubMed ID: 7983505
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer].
Taguchi T; Ohta J; Orino M; Ohshiba S; Yamada S; Okazima K; Ohtani T; Hurukawa H; Iwanaga T; Numata N
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2191-6. PubMed ID: 2241183
[TBL] [Abstract][Full Text] [Related]
9. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.
Wilke H; Preusser P; Fink U; Gunzer U; Meyer HJ; Meyer J; Siewert JR; Achterrath W; Lenaz L; Knipp H
J Clin Oncol; 1989 Sep; 7(9):1318-26. PubMed ID: 2769330
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
Sparano JA; Schwartz EL; Salva KM; Pizzillo MF; Wadler S; Wiernik PH
Am J Clin Oncol; 1990 Oct; 13(5):374-8. PubMed ID: 2220657
[TBL] [Abstract][Full Text] [Related]
12. Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule.
Gebbia V; Valenza R; Testa A; Sciume C; Longo A; Cipolla C; Borsellino N; Leo P; Latteri M; Florena M
J Cancer Res Clin Oncol; 1994; 120(9):550-2. PubMed ID: 8045920
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
[TBL] [Abstract][Full Text] [Related]
14. Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: a pilot study.
Yeh KH; Cheng AL; Chen YC; Chen BR; Lee WJ; Lin JT; Lee PH; Chang KJ; Wang CH; Wang TH
J Formos Med Assoc; 1994 Jan; 93(1):20-4. PubMed ID: 7915575
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
Wang X; Pang L; Feng J
Am J Clin Oncol; 2002 Feb; 25(1):71-5. PubMed ID: 11823701
[TBL] [Abstract][Full Text] [Related]
16. Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.
Lerner A; Gonin R; Steele GD; Mayer RJ
J Clin Oncol; 1992 Apr; 10(4):536-40. PubMed ID: 1548518
[TBL] [Abstract][Full Text] [Related]
17. Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)".
Räth U; Flechtner H; Selbach J; Harjung H; Manegold C; Kabelitz K; Trux FA; Edler L; Schlag P; Queisser W
Onkologie; 1990 Jun; 13(3):194-7. PubMed ID: 2204005
[TBL] [Abstract][Full Text] [Related]
18. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer.
Chiou TJ; Tung SL; Hsieh RK; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Jpn J Clin Oncol; 1998 May; 28(5):318-22. PubMed ID: 9703859
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
